Brief: Aptose Reports Results For The Third Quarter 2020
10/11/2020 21:46
Nov 10 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE THIRD QUARTER 2020
* QTRLY LOSS PER SHARE $0.15
* EXPECTS CASH ON HAND PROVIDES SUFFICIENT RESOURCES TO
FUND
PLANNED OPERATIONS INTO 2023
* TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF
SEPTEMBER
30, 2020 WERE $132.7 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX66RRXS
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting